Valuation
Dental Practice Valuation: What Is It Worth?
How dental practice valuation actually works in the US, with real multiples, a worked example, and what moves value up or down before a sale.
Two buyers. Two different answers.
A general dentist selling to another dentist and a multi-location group selling to a DSO are answering two different financial questions, even though both call it "valuation." The first is pricing an income stream one buyer will personally replace. The second is pricing transferable cash flow after a market-rate clinician and manager are already paid. Collapsing the two into a single multiple is the most common mistake we see owners make before they ever talk to an advisor.
This page walks through the multiples that actually apply, how they differ by buyer type, a worked example with real numbers, and the specific things that move a dental practice's value up or down.
01
Dental Practice Multiples Today
| Transaction basis | Range | What it applies to |
|---|---|---|
| Traditional dentist-to-dentist sale | 65% to 85% of average three-year collections | Solo or small owner-operated practice, ADA rule of thumb |
| Closed sales, revenue basis (BizBuySell, 2021-2025) | 0.51x to 0.86x revenue (interquartile) | Public benchmark for smaller main-street sales |
| Closed sales, SDE basis (BizBuySell, 2021-2025) | 1.60x to 3.37x SDE (interquartile) | Owner-buyer replacing the seller clinically |
| DSO tuck-in / add-on practice | 3.0x to 6.0x adjusted EBITDA | Profitable practice joining an existing group |
| PE-backed DSO acquisition | 4.0x to 7.0x EBITDA, or 1.0x to 1.5x revenue | Larger or multi-doctor group |
| New DSO platform purchase | Around 8.0x EBITDA | Scale, systems, provider depth, add-on pipeline |
| Sale of a scaled DSO to another sponsor | 10.0x to 12.0x EBITDA | The consolidated organization, not individual clinics |
According to closed-sale data reported by BizBuySell for 2021 through 2025, the middle 50% of sold dental practices priced between 0.51x and 0.86x revenue, or 1.60x to 3.37x seller's discretionary earnings (SDE). Those numbers reflect real closed transactions, not asking prices, which makes them a more grounded benchmark than most rule-of-thumb figures circulating online. On the institutional side, Lincoln International's 2025 dental sector report puts DSO tuck-in acquisitions at 3.0x to 6.0x adjusted EBITDA, while Mercer Capital's Q1 2025 Healthcare Facilities report places PE-backed DSO acquisitions at 4.0x to 7.0x EBITDA and platform-level exits between scaled DSOs at 10.0x to 12.0x EBITDA.
Do not blend these mechanically. A 0.75x collections result and a 6.0x EBITDA result are answering different buyer questions, and averaging them produces a number that means nothing to either buyer type.
02
The Three Ways Dental Practices Get Valued
Collections multiple. Take average patient collections, not gross production or gross charges, over the last three completed years, and apply 65% to 85%. This is the ADA's long-standing rule of thumb and it remains the fastest first-pass screen for a stable, owner-operated practice. It ignores profitability entirely, which is its weakness: two practices with identical collections can have very different take-home.
Seller's discretionary earnings (SDE). SDE = pretax profit + one working owner's compensation and benefits + interest + depreciation + amortization + documented non-recurring or discretionary expenses. This is the right lens when a single dentist-buyer will personally step into the seller's clinical role, because it assumes the buyer, not a hired associate, is doing the dentistry. Closed-sale data puts this at 1.60x to 3.37x SDE.
Adjusted EBITDA. This is the DSO and institutional lens. Adjusted EBITDA = operating profit before interest, tax, depreciation and amortization, plus defensible one-time add-backs, minus market-rate owner clinical compensation, minus any missing market-rate management cost, minus rent normalization to market. A common approach is to replace the owner-dentist's clinical labor with roughly 30% to 35% of that owner's personal production, adjusted for specialty and local associate rates. Get this step wrong and the value is badly overstated, because you're claiming the owner's own labor as pure profit.
Cross-check at least two of these methods before treating a number as real.
03
Worked Example: A $1.2 Million Collections Practice
Take a general practice averaging $1.2 million in patient collections over the last three years, run by a single owner-dentist with one hygienist and modest overhead.
Collections method: $1.2M x 0.65 to 0.85 = $780,000 to $1,020,000.
SDE cross-check. Suppose after adding back the owner's salary, benefits, interest, depreciation and a handful of documented discretionary expenses, SDE comes to $420,000. At the closed-sale interquartile range of 1.60x to 3.37x SDE, that's $672,000 to $1,415,400, with the median multiple (2.48x) landing at roughly $1,041,600.
Where the two methods agree is the practical answer: the collections range and the middle of the SDE range both point toward roughly $780,000 to $1,040,000 as a defensible first-pass value for this practice, assuming clean books, no major lease or compliance issues, and stable patient flow. A buyer's dentist and lender will still want three to five years of tax returns, procedure mix, A/R aging and payer mix before that number becomes an offer.
If this same practice were instead evaluated by a DSO on adjusted EBITDA (after normalizing the owner's clinical compensation to a market associate rate), the multiple basis shifts to 3.0x to 6.0x adjusted EBITDA, which is a different calculation entirely and typically produces a different headline number, not necessarily a higher one once compensation is normalized.
Coming soon. Our indicative valuation tool is in development - in the meantime, contact us for a confidential, no-obligation view on what your business could be worth.
04
What Moves Dental Practice Value Up or Down
Pushes value higher:
- Three years of stable or growing collections with clean monthly reporting.
- Multiple producing dentists, low dependence on the selling owner, and signed associate agreements with low provider turnover.
- Strong hygiene recall, active-patient retention, and steady new-patient flow.
- Fee-for-service and commercially insured revenue, with limited concentration in any single payer.
- Specialty scarcity, particularly orthodontics, oral surgery and endodontics, where referral relationships and providers are actually transferable.
- Multiple locations under one practice-management system with real centralized reporting.
- A long, assignable lease at market rent, adequate operatories, and no looming capital expenditure.
- A competitive sale process. FOCUS Investment Banking's 2025 dental transactions update found final DSO offers can differ by 40% or more in total amount and structure, which is a strong argument for running a real process rather than accepting the first offer.
Pulls value lower:
- Declining collections, weak new-patient counts, poor recall, or stale patient charts.
- A seller who generates most of the doctor production and won't stay long enough to transfer relationships.
- Medicaid, capitation, or single-PPO concentration with reimbursement below sustainable cost.
- Hygienist vacancies, undocumented contractor arrangements, or deferred wage adjustments.
- Unreconciled A/R aging, credit balances, prepaid treatment, or unfinished cases.
- A short or non-assignable lease, above-market rent, or unresolved landlord consent.
- Board investigations, malpractice claims, billing or coding concerns, HIPAA gaps, or undisclosed liens.
- Old equipment, unsupported practice-management software, or immediate capital needs.
05
DSO vs. Private Buyer: Two Different Deals
More than 240 U.S. dental transactions were reported in 2024, the highest count among eleven physician-practice specialties tracked by VMG Health, and 16.1% of U.S. dentists were DSO-affiliated in 2024, up from 10.4% in 2019. That growth means most sellers of any real size will get looked at by at least one DSO, but a DSO offer and a private-buyer offer are structured very differently.
A private dentist buyer is typically financing an asset purchase through an SBA or bank loan, paying close to 100% cash at closing, and stepping directly into the clinical role. Pricing clusters around the collections and SDE ranges above.
A DSO's headline number is normally enterprise value, not guaranteed cash at closing. FOCUS reports that 100% cash is rare in PE-backed DSO sales; consideration often includes rollover equity, an earnout, or a seller note, and Mercer Capital notes that a DSO commonly buys at least 70% of practice equity while leaving a rollover option on the rest. A higher headline multiple can still produce lower risk-adjusted proceeds than a smaller all-cash private sale, if a large share of the value depends on future production, buyer refinancing, or illiquid rollover equity. Compare cash at closing, escrow terms, rollover percentage and security, earnout formula, seller note priority, and required post-close employment term, which commonly runs six to twelve months in a traditional sale and can run three to five years under a DSO agreement where the owner drives most of the production.
For most healthcare owners weighing these paths, it helps to see how dental fits inside broader healthcare sector M&A and the dental practice buyer landscape specifically before choosing a direction.
06
Frequently Asked Questions
A stable solo practice often screens at 65% to 85% of average three-year collections. Closed BizBuySell observations put the middle 50% of sold practices at 0.51x to 0.86x revenue and 1.60x to 3.37x SDE. Profitable DSO targets can price at 3.0x to 6.0x adjusted EBITDA, depending on size and buyer.
Only for a rough range. Average the last three years of actual collections and multiply by 0.65 to 0.85, then cross-check against normalized SDE or EBITDA, local closed sales, lease terms, payer mix, provider dependence, and near-term capital needs. No calculator can price tax allocation, rollover risk, or buyer-specific synergies, which is why a preliminary number and a defensible valuation are not the same thing.
Collections and SDE fit a small practice where one dentist-buyer replaces the seller. Adjusted EBITDA fits a DSO or investor buying transferable profit after paying a replacement clinician and manager. Run at least two methods as cross-checks rather than relying on one.
Not necessarily. A DSO may offer a higher enterprise-value multiple for strong transferable EBITDA, but part of that number can be rollover equity, an earnout, or deferred payment. Compare after-tax cash at close and employment obligations, not just the headline multiple.
Traditional private sales commonly include six to twelve months of seller employment for transition, though some deals require only introductions and a short handover. DSO arrangements can require three to five years, especially where the seller drives most of the production or referral relationships.